18F-DCFPyL (PSMA) PET as a radiotherapy response assessment tool in metastatic prostate cancer

18F-DCFPyL (PSMA) PET as a radiotherapy response assessment tool in metastatic prostate cancer

Background: Prostate Specific Membrane Antigen (PSMA) – positron emission tomography (PET) guides metastasis-directed radiotherapy (MDRT) in prostate cancer (PrCa). However, its value as a treatment response assessment tool after MDRT remains unclear. Importantly, there is limited understanding of t...

Full description

Bibliographic Details
Main Authors: Aruz Mesci, Elham Ahmadi, Amr Ali, Mohammad Gouran-Savadkoohi, Evangelia Evelyn Tsakiridis, Olga-Demetra Biziotis, Tom Chow, Anil Kapoor, Monalisa Sur, Gregory R. Steinberg, Stanley Liu, Katherine Zukotynski, Theodoros Tsakiridis
Format: Article
Language:English
Published: Elsevier 2023-03-01
Series:Clinical and Translational Radiation Oncology
Subjects:
PSMA-PET
FOLH1 expression
Immunohistochemistry
qPCR
Radio-resistance
Tumor heterogeneity
Online Access:http://www.sciencedirect.com/science/article/pii/S2405630823000083

Internet

http://www.sciencedirect.com/science/article/pii/S2405630823000083

Similar Items